Pipeline
Our clinical pipeline builds on years of innovation and in-house expertise at Cebiotex. Powered by our proprietary CEB Platform Technology, a breakthrough nanofiber-based system for precise local drug delivery, we develop tailored solutions for diverse oncological indications.
*Orphan Drug Designation by EMA and FDA.
**Orphan Drug Designation by EMA.
***Indications in the basket trial include Wilms tumour, germ cell tumour, extracranial malignant rhabdoid tumour, synovial sarcoma, desmoplastic small round cell tumour and fibrolamellar hepatocellular carcinoma.